Pravastatin + Sofosbuvir%2C Velpatasvir%2C And Voxilaprevir Interaction
Moderateinteraction on record
Description
HMG-CoA Reductase Inhibitors: pravastatin ↑ pravastatin Coadministration of VOSEVI with pravastatin has been shown to increase the concentration of pravastatin, which is associated with increased risk of myopathy, including rhabdomyolysis. Pravastatin may be administered with VOSEVI at a dose that does not exceed pravastatin 40 mg.
Source: FDA drug label - sofosbuvir, velpatasvir, and voxilaprevir